The Translational Value of Calcium Pyrophosphate Deposition Disease Experimental Mouse Models

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2024 Jun 7

PMID 38846138

Authors

Roberto Luisetto

Anna Scanu

Affiliations

Soon will be listed here.

Abstract

The deposition of calcium pyrophosphate (CPP) crystals in joint tissues causes acute and chronic arthritis that commonly affect the adult and elderly population. Experimental calcium pyrophosphate deposition disease (CPPD) models are divided into genetically modified models and crystal-induced inflammation models. The former do not reproduce phenotypes overlapping with the human disease, while in the latter, the direct injection of crystals into the ankles, dorsal air pouch or peritoneum constitutes a useful and reliable methodology that resembles the CPP induced-inflammatory condition in humans. The translational importance of the induced model is also strengthened by the fact that the key molecular and cellular mediators involved in inflammation are shared between humans and laboratory rodents. Although, models are indispensable tools for studying the pathogenesis of the CPPD and testing new therapies, their development is still at an early stage and major efforts are needed to address this issue. Here, we analyze the strenghts and limitations of each currently available CPPD model, and critically discuss their translational value.

References

Campillo-Gimenez L, Renaudin F, Jalabert M, Gras P, Gosset M, Rey C . Inflammatory Potential of Four Different Phases of Calcium Pyrophosphate Relies on NF-κB Activation and MAPK Pathways. Front Immunol. 2018; 9:2248. PMC: 6189479. DOI: 10.3389/fimmu.2018.02248. View

Mitton-Fitzgerald E, Gohr C, Bettendorf B, Rosenthal A . The Role of ANK in Calcium Pyrophosphate Deposition Disease. Curr Rheumatol Rep. 2016; 18(5):25. PMC: 5453179. DOI: 10.1007/s11926-016-0574-z. View

Onai N, Ogasawara C . Calcium Pyrophosphate Dihydrate Crystals Increase the Granulocyte/Monocyte Progenitor (GMP) and Enhance Granulocyte and Monocyte Differentiation In Vivo. Int J Mol Sci. 2021; 22(1). PMC: 7794855. DOI: 10.3390/ijms22010262. View

OConnell K, Mikkola A, Stepanek A, Vernet A, Hall C, Sun C . Practical murine hematopathology: a comparative review and implications for research. Comp Med. 2015; 65(2):96-113. PMC: 4408895. View

Joosten L, Netea M, Mylona E, Koenders M, Malireddi R, Oosting M . Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 2010; 62(11):3237-48. PMC: 2970687. DOI: 10.1002/art.27667. View

Rehli M . Of mice and men: species variations of Toll-like receptor expression. Trends Immunol. 2002; 23(8):375-8. DOI: 10.1016/s1471-4906(02)02259-7. View

Abhishek A, Doherty M . Update on calcium pyrophosphate deposition. Clin Exp Rheumatol. 2016; 34(4 Suppl 98):32-8. View

Sakamoto M, Hosoda Y, Kojimahara K, Yamazaki T, Yoshimura Y . Arthritis and ankylosis in twy mice with hereditary multiple osteochondral lesions: with special reference to calcium deposition. Pathol Int. 1994; 44(6):420-7. DOI: 10.1111/j.1440-1827.1994.tb01705.x. View

Nitschke Y, Yan Y, Buers I, Kintziger K, Askew K, Rutsch F . ENPP1-Fc prevents neointima formation in generalized arterial calcification of infancy through the generation of AMP. Exp Mol Med. 2018; 50(10):1-12. PMC: 6204430. DOI: 10.1038/s12276-018-0163-5. View

10.

Harmey D, Johnson K, Zelken J, Camacho N, Hoylaerts M, Noda M . Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2(-/-) mice. J Bone Miner Res. 2006; 21(9):1377-86. DOI: 10.1359/jbmr.060619. View

11.

Ea H, Chobaz V, Nguyen C, Nasi S, van Lent P, Daudon M . Pathogenic role of basic calcium phosphate crystals in destructive arthropathies. PLoS One. 2013; 8(2):e57352. PMC: 3585350. DOI: 10.1371/journal.pone.0057352. View

12.

Hackert N, Radtke F, Exner T, Lorenz H, Muller-Tidow C, Nigrovic P . Human and mouse neutrophils share core transcriptional programs in both homeostatic and inflamed contexts. Nat Commun. 2023; 14(1):8133. PMC: 10709367. DOI: 10.1038/s41467-023-43573-9. View

13.

Zhang W, Doherty M, Bardin T, Barskova V, Guerne P, Jansen T . European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011; 70(4):563-70. DOI: 10.1136/ard.2010.139105. View

14.

Punzi L, Scanu A, Spinella P, Galozzi P, Oliviero F . One year in review 2018: gout. Clin Exp Rheumatol. 2019; 37(1):1-11. View

15.

Modi W, Yoshimura T . Isolation of novel GRO genes and a phylogenetic analysis of the CXC chemokine subfamily in mammals. Mol Biol Evol. 1999; 16(2):180-93. DOI: 10.1093/oxfordjournals.molbev.a026101. View

16.

Masuda I, Hirose J . Animal models of pathologic calcification. Curr Opin Rheumatol. 2002; 14(3):287-91. DOI: 10.1097/00002281-200205000-00016. View

17.

Okawa A, Nakamura I, Goto S, Moriya H, Nakamura Y, Ikegawa S . Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat Genet. 1998; 19(3):271-3. DOI: 10.1038/956. View

18.

Bertrand J, Nitschke Y, Fuerst M, Hermann S, Schafers M, Sherwood J . Decreased levels of nucleotide pyrophosphatase phosphodiesterase 1 are associated with cartilage calcification in osteoarthritis and trigger osteoarthritic changes in mice. Ann Rheum Dis. 2012; 71(7):1249-53. DOI: 10.1136/annrheumdis-2011-200892. View

19.

Zhou X, Cui Y, Zhou X, Han J . Phosphate/pyrophosphate and MV-related proteins in mineralisation: discoveries from mouse models. Int J Biol Sci. 2012; 8(6):778-90. PMC: 3372882. DOI: 10.7150/ijbs.4538. View

20.

Uzuki M, Sawai T, Ryan L, Rosenthal A, Masuda I . Upregulation of ANK protein expression in joint tissue in calcium pyrophosphate dihydrate crystal deposition disease. J Rheumatol. 2013; 41(1):65-74. PMC: 6240442. DOI: 10.3899/jrheum.111476. View